New heart valve device shows promise for aortic stenosis patients
NCT ID NCT06510855
First seen May 17, 2026 · Last updated May 24, 2026 · Updated 1 time
Summary
This study is testing a new device called the DurAVR™ THV system for people with severe aortic stenosis, a condition where the heart's aortic valve becomes narrow and stiff. The study involves 40 participants who need a valve replacement and are eligible for a minimally invasive procedure called TAVR. The main goal is to check if the device is safe and works well by looking at rates of death or disabling stroke within 30 days after the procedure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AORTIC VALVE DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Rigshospitalet
Copenhagen, Capital Region of Denmark, 2100, Denmark
Conditions
Explore the condition pages connected to this study.